In addition, analysis of the GSE 4290 dataset of patients with glioma showed that levels of PD-L1 are higher in the GBM group than in the low-grade astrocytoma groups (grade II and grade III) and the non-tumor group (Figure S1A). The gene discussed is CD274; the disease is glioblastoma.